Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Public ClinicalTrials.gov record NCT01359566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of three doses of XP19986 (arbaclofen placarbil) compared to placebo for the treatment of spasticity in subjects with multiple sclerosis (MS).
Study identification
- NCT ID
- NCT01359566
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Interventions
- Arbaclofen placarbil 15 mg BID Drug
- Placebo Drug
- Arbaclofen placarbil 30 mg BID Drug
- Arbaclofen placarbil 45 mg BID Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2011 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- Feb 2013 (Actual)
- Last update posted
- Feb 21, 2021
2011 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| XenoPort Clinical Site | Phoenix | Arizona | 85004 | — |
| XenoPort Clinical Site | Tucson | Arizona | 85701 | — |
| XenoPort Clinical Site | Berkeley | California | 94705 | — |
| XenoPort Clinical Site | San Diego | California | 92103 | — |
| XenoPort Clinical Site | Denver | Colorado | 80012 | — |
| XenoPort Clinical Site | Port Charlotte | Florida | 33948 | — |
| XenoPort Clinical Site | Sarasota | Florida | 34231 | — |
| XenoPort Clinical Site | St. Petersburg | Florida | 33701 | — |
| XenoPort Clinical Site | Tampa | Florida | 33604 | — |
| XenoPort Clinical Site | Lake Barrington | Illinois | 60010 | — |
| XenoPort Clinical Site | Indianapolis | Indiana | 46204 | — |
| XenoPort Clinical Site | Lenexa | Kansas | 66210 | — |
| XenoPort Clinical Site | Lexington | Kentucky | 40505 | — |
| XenoPort Clinical Site | Bingham Farms | Michigan | 48025 | — |
| XenoPort Clinical Site | Detroit | Michigan | 48202 | — |
| XenoPort Clinical Site | Toms River | New Jersey | 08753 | — |
| XenoPort Clinical Site | Albuquerque | New Mexico | 87102 | — |
| XenoPort Clinical Site | Albany | New York | 12208 | — |
| XenoPort Clinical Site | Patchogue | New York | 11772 | — |
| XenoPort Clinical Site | Plainview | New York | 11803 | — |
| XenoPort Clinical Site | Asheville | North Carolina | 28805 | — |
| XenoPort Clinical Site | Akron | Ohio | 44320 | — |
| XenoPort Clinical Site | Franklin | Tennessee | 37064 | — |
| XenoPort Clinical Site | Nashville | Tennessee | 37205 | — |
| XenoPort Clinical Site | San Antonio | Texas | 78206 | — |
| XenoPort Clinical Site | Vienna | Virginia | 22181 | — |
| XenoPort Clinical Site | Seattle | Washington | 98108 | — |
| XenoPort Clinical Site | Tacoma | Washington | 98404 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01359566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01359566 live on ClinicalTrials.gov.